RING CHRISTINE (General Counsel) sold 30.8% of their position (8.15K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $138.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/4/2026ACC: 0001817199-26-000018
Officer· General Counsel
Since Jul 2020
-8.15K
Net shares
Net seller
$138.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.15K
Price / share
$16.96
Trade value
$138.21K
% of position
30.8%
5/4/2026
26.45K→18.30K
Total
Net shares
−8.15K
Net value
-$138.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | S · Sale | −8.15K | $16.96 | $138.21K | 30.8% | 26.45K | 18.30K |
| Total | −8.15K | -$138.21K | ||||||
Derivative Transactions0
No derivative transactions reported